Navigation Links
Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
Date:11/29/2007

NEW YORK, Nov. 29 /PRNewswire-USNewswire/ -- In keeping with The Michael J. Fox Foundation's mission to accelerate scientific breakthroughs that can transform the lives of people with Parkinson's disease, the Foundation today announced the appointment of Irene Hegeman Richard, MD, to the newly created role of Senior Medical Advisor. This appointment formalizes the role of Dr. Richard, who is associate professor of neurology and psychiatry at the University of Rochester School of Medicine and Dentistry, in helping to inform and develop MJFF's clinical agenda.

Dr. Richard brings experience in running large-scale Parkinson's trials and is familiar with the challenges facing this research area. Formalizing her role as advisor to the Foundation will help ensure that MJFF's increasing involvement in clinical trials, including trial design and regulatory issues, is as efficient and targeted as possible. She will also provide important feedback on pre-clinical experimental design, helping to ensure that all studies funded by MJFF --- not only those requiring the active involvement of patients --- are designed with potential clinical issues in mind.

"Irene's clinical research perspective complements the scientific expertise of Gene Johnson, PhD, MJFF's chief scientific advisor, and her input will be a boon to our research staff and advisors in continually raising the bar on the patient-relevant outcomes we expect from every project we fund," said Katie Hood, interim CEO of The Michael J. Fox Foundation. "Additionally, as a clinician with an active neurology practice, Irene has a deep understanding of the challenges faced every day by people living with PD --- something the Foundation values deeply, since patients are at the center of every activity we undertake."

Dr. Richard has served on the Foundation's SAB since 2006. She also has been a member of the review committee for the Foundation's annual Clinical Discovery Program, which funds hig
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
2. William Moore Appointed to IRIDEX Board of Directors
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
5. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
6. James B. Hawkins Appointed to IRIDEX Board of Directors
7. Bryan R. Rogers Appointed President of Far West Division
8. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
9. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
10. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
11. Oral Health a Matter of Life and Death for Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Bladder cancer is much more likely to be deadly ...ong believed to explain the phenomenon account for...mpared to their white and male counterparts, accor...he journal Cancer . , The results present a sta...r type, and stage of the disease upon diagnosis do...
(Date:1/8/2009)..., Positive agency reception sets stage for produ...wire/ -- The Medicare Advocacy Recovery Coalition ...re Secondary Payor reform, laid the groundwork for...llowing its inaugural meeting with officials from ...). , , "Our purpose was to introduce MARC as an...
(Date:1/8/2009)... Keeping an eye on pets d... Tampa, FL (Vocus) January 9, 2009 -- In re...erinary Specialists (FVS) are spreading the word ...e pets are as susceptible as humans.  &n...do so quickly," said Dr. Noelle McNabb, DVM, ...
(Date:1/8/2009)...Treatment may reduce risk of cardiovascular diseas...-- Here,s a wake-up call to the millions of Americ...night or nodding off during the day may be symptom...hreatening problem affecting one out of three diab...inking the two disorders, global health experts ar...
Breaking Medicine News(10 mins):Health News:Why bladder cancer is deadlier for some 2Health News:Why bladder cancer is deadlier for some 3Health News:Why bladder cancer is deadlier for some 4Health News:MARC Coalition Holds Initial Meeting With CMS; Announces New Members 2Health News:Glaucoma Awareness Not Just for Humans 2Health News:Glaucoma Awareness Not Just for Humans 3Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 2Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 3
...ants were dug out from the gutter of Ratlam's Chri...intendent P. Williams, detained earlier following ...continued in the compound of the hospital and more... aborted fetuses and of baby girls, recovered from...
...ut that women with a 34 inch waist carry twice the...to women who boast of trimmer waists. Nearly 5500...e that has gone up by 19% as compared to the figur... much trimmer and therefore did not suffer the gra...
...was found to bring down the androgen levels in wom...n Demirel University in Isparta, Turkey. Hirsutis...of excessive hair in the face, breasts and stomach...eased level of male hormone, androgen which is res...
...chers have given their opinion- Nature’s way is fa...those decided solely upon by the mother, in spite ...lts published in the Canadian Medical Association ...an who opts for a C-section, in spite of her docto...
Other Medicine News:Health News:More Bones of Aborted Fetuses Recovered from Hospital Premises 2Health News:Cancer Risk Pronounced in Women With an Ample Waist 2
(Date:1/6/2009)...Jan. 6 The Michael J. F...n to four industry research teams for pre-clinical...n,s disease. , , The funding was awarded under ...ive. This program, first launched in 2006, suppor...son,s research. TDI is part of MJFF,s focus on ...
(Date:1/6/2009)... France, January 6 , ... Collaboration Until,December 2011 , - Exp...e Antibody,Discovery in Ophthalmology , - ...f Allergan,Sublicenses to a Third Party , ...nounced a reinforcement,of its existing drug disc...
(Date:1/3/2009)... , , ROSEMONT, Ill., Jan. 2 /PRNewswi... is a growing technology providing an increasing n...tion of back pain according to an article in the J...cademy of Orthopaedic Surgeons ( http://www.jaaos....l years, additional technical developments will al...
(Date:12/27/2008)...MAS, Calif., Dec. 27 According to ...st advised to consume modest doses of,resveratrol...ly provided in 3,to 5 glasses of aged, red wine, ...http://www.newscom.com/cgi-bin/prnh/20080603/LATU0...se resveratrol alone fails to prolong,the life of...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines 7712 1Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines 7712 2Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 1Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 2Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 3Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 4Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 5NIEHS invests 2421 25 million to find environmental causes of Parkinsons disease 4906 1NIEHS invests 2421 25 million to find environmental causes of Parkinsons disease 4906 2NIEHS invests 2421 25 million to find environmental causes of Parkinsons disease 4906 3Expert urges FDA to take action to reduce BPA exposure 4904 1Expert urges FDA to take action to reduce BPA exposure 4904 2
...ng,poliomyelitis from the remaining infected count... than the long term costs of trying,to control inf...ped,monovalent vaccine is almost three times more ...sting trivalent vaccine. These are,the findings of...issue of The Lancet. , Both Articles look at the s...
...), a,biopharmaceutical company specializing in dev...Lipoprotein (HDL), often called,"good cholesterol,...s of the Phase I/II Clinical Trial of its lead pro...ent of dyslipidemia and,heart disease. , A detaile...,blood chemistry and blood pressure measurements w...
Other Medicine Technology:Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3
The OraQuick ADVANCE Rapid HIV-1/2 Antibody Test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingers
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple
Standard Trephine
Coronet Vacuum Trephine - All metal, ergonomic design and ultra sharp blade with cross hairs.
Medicine Products: